Nuclein, founded with a mission to revolutionize infectious disease diagnostics, focuses on creating user-friendly, disposable testing devices that require no technical expertise. Their flagship product, the DASH™ Rapid PCR System, is a point-of-care platform that delivers central lab-quality results in minutes. This battery-powered, all-in-one device is designed for a wide range of sample types and is ideal for CLIA-waived environments, making high-quality diagnostics accessible and straightforward.
Notable figures associated with Nuclein include Chad Achenbach, M.D., who serves as an Associate Director. The company has achieved significant milestones in simplifying and expediting the PCR testing process, providing best-in-class sensitivity and ease of use comparable to operating a coffee maker. Nuclein's innovations have had a considerable impact on the biotechnology sector by enhancing the accessibility and efficiency of infectious disease diagnostics.
